EUVIMEDEUVIMED entdecken
Crossref

Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia

Yu Wang, Yu-Juan Xue, Yue-Ping Jia, Ying-Xi Zuo, Ai-Dong Lu, Le-Ping Zhang

Acta Haematologica · 2023

DOI: 10.1159/000530849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Haematologica, 2023. Verfasst von Yu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The prognostic significance of CD20 in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) remains unclear. Therefore, in this study, we evaluated the prognostic value of CD20 expression in leukemia blasts in pediatric BCP-ALL at our institute.

Methods

Between 2005 and 2017, 796 children with newly diagnosed Philadelphia-negative BCP-ALL were enrolled consecutively; clinical characteristics and treatment outcomes were analyzed and compared between CD20-positive and CD20-negative groups.

Results

CD20 positivity was observed in 22.7% of enrolled patients. The analysis of overall and event-free survival showed that white blood cell count ≥50 × 109/L, no ETV6-RUNX1, day 33 minimal residual disease (MRD) ≥0.1%, and week 12 MRD ≥0.01% were independent risk factors. Meanwhile, in the CD20-positive group, week 12 MRD ≥0.01% was the only factor associated with long-term survival. Moreover, subgroup analysis revealed that in patients with extramedullary involvement (p = 0.047), MRD ≥0.1% on day 33 (p = 0.032), or MRD ≥0.01% at week 12 (p = 0.004), CD20 expression led to a poorer outcome compared to those without CD20 expression.

Conclusions

Pediatric BCP-ALL with CD20 expression had unique clinicopathological characteristics, and MRD remained the major prognostic factor. CD20 expression had no prognostic value in pediatric BCP-ALL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansChildPrognosisPhiladelphia ChromosomeTreatment OutcomeAcute DiseaseNeoplasm, Residual

Stichwörter der Autor:innen

B-cell precursor acute lymphoblastic leukemiaCD20Minimal residual diseasePediatricPhiladelphia-negative

Autor:innen und Institutionen

  • Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.

Zitieren

APA

Wang, Y., Xue, Y. J., Jia, Y. P., Zuo, Y. X., Lu, A. D., & Zhang, L. P. (2023). Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia. Acta Haematologica. https://doi.org/10.1159/000530849

Vancouver

Wang Y, Xue YJ, Jia YP, Zuo YX, Lu AD, Zhang LP. Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia. Acta Haematologica. 2023. doi:10.1159/000530849

BibTeX
@article{Wang2023,
  author = {Wang, Yu and Xue, Yu-Juan and Jia, Yue-Ping and Zuo, Ying-Xi and Lu, Ai-Dong and Zhang, Le-Ping},
  title = {Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia},
  journal = {Acta Haematologica},
  year = {2023},
  doi = {10.1159/000530849}
}
Kostenlos starten →